Group A and C meningococcal polysaccharide conjugate vaccine - Beijing Zhifei Lvzhu Biopharmaceutical
Latest Information Update: 19 Apr 2024
At a glance
- Originator Beijing Zhifei Lvzhu Biopharmaceutical
- Class Conjugate vaccines; Meningococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Meningococcal group A infections; Meningococcal group C infections
Most Recent Events
- 17 Sep 2021 Phase-III clinical trials in Meningococcal group A infections (In children, Prevention) in China (IM) (NCT06314659)
- 17 Sep 2021 Phase-III clinical trials in Meningococcal group C infections (In children, Prevention) in China (IM) (NCT06314659)